Enzymotec And Polar Omega A/S Sign A Joint Venture Agreement

MIGDAL HA'EMEQ, Israel and ESBJERG, Denmark, Dec. 4, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, and Polar Omega A/S, a Danish company specializing in the production of marine phospholipids from sustainable fish sources, announced today that they have signed a joint venture (JV) agreement for the commercialization of Omega PC™, a new premium fish based omega-3 product.

Help employers find you! Check out all the jobs and post your resume.